Genome-Wide Analysis of Transcriptional Reprogramming in Mouse Models of Acute Myeloid Leukaemia
Author Information
Author(s): Bonadies Nicolas, Foster Samuel D., Chan Wai-In, Kvinlaug Brynn T., Spensberger Dominik, Dawson Mark A., Spooncer Elaine, Whetton Anthony D., Bannister Andrew J., Huntly Brian J., Göttgens Berthold
Primary Institution: Department of Haematology, Cambridge Institute for Medical Research, Cambridge University
Hypothesis
What are the mechanisms underlying large-scale transcriptional reprogramming in acute myeloid leukaemia?
Conclusion
The study identifies downregulation of Gata2 as a significant factor in the transcriptional reprogramming associated with acute myeloid leukaemia.
Supporting Evidence
- The study identified several thousand candidate regulatory regions with altered levels of histone acetylation.
- Downregulation of Gata2 was associated with leukaemogenic transcriptional reprogramming.
- Higher expression of GATA2 was found in CD34+ cells from healthy controls compared to AML blast cells.
Takeaway
Researchers studied how certain genes change when mice develop leukemia, finding that a gene called Gata2 is important for keeping blood cells healthy.
Methodology
The study used gene-expression profiling and ChIP-sequencing in mouse models of acute myeloid leukaemia to analyze transcriptional changes.
Limitations
The findings from mouse models may not fully translate to human AML due to biological differences.
Participant Demographics
Mouse models were used, specifically lineage negative/c-kit positive bone marrow cells.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website